The North America Wearable Patch Market is expected to witness market growth of 10.41% CAGR during the forecast period (2020-2026).
A wearable patch is alternately called electronic skin or smart patch. They are used to diagnosis, monitor diseases, and drug delivery. It is also helpful in maintaining the health of aging patients suffering from any chronic disease. The market is anticipated to show profitable growth, due to rising R&D investment for the advancement of wearable patches. A nicotine patch is useful in Nicotine Replacement Therapy (NRT), which helps in preventing smoking.
The main factor boosting the market is the growing prevalence of chronic diseases like atrial fibrillation and diabetes that are causing stroke incidents at a very higher rate, which is likely to drive the market in coming years. For instance, as per the International Diabetes Federation Report, about 463.0 million adults were suffering from diabetes across the globe. In addition to it, it is expected that about 700.0 million people may suffer from diabetes by the end 2045 all across the globe.
Similarly, the growing occurrence of atrial fibrillation is the key factor boosting the market. As per the American Heart Association Report, stroke is the prominent cause of death in the U.S., and about 2.7 million people in the country are already suffering from atrial fibrillation. It is also expected that every year, 800,000 cases of stroke has been recorded due to blockage in blood vessels.
Based on Technology, the market is segmented into Connected Wearable and Regular Wearable. Based on Application, the market is segmented into Non-Clinical and Clinical. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include DexCom, Inc., Abbott Laboratories, Koninklijke Philips N.V., Smith & Nephew PLC (Leaf Healthcare, Inc.), Qualcomm, Inc., L'Oreal Group, VivaLNK, Inc., Cardiac Insight, Inc., AliveCor, Inc. and LifeSignals Group, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Technology
By Application
By Country
Companies Profiled
Unique Offerings
A wearable patch is alternately called electronic skin or smart patch. They are used to diagnosis, monitor diseases, and drug delivery. It is also helpful in maintaining the health of aging patients suffering from any chronic disease. The market is anticipated to show profitable growth, due to rising R&D investment for the advancement of wearable patches. A nicotine patch is useful in Nicotine Replacement Therapy (NRT), which helps in preventing smoking.
The main factor boosting the market is the growing prevalence of chronic diseases like atrial fibrillation and diabetes that are causing stroke incidents at a very higher rate, which is likely to drive the market in coming years. For instance, as per the International Diabetes Federation Report, about 463.0 million adults were suffering from diabetes across the globe. In addition to it, it is expected that about 700.0 million people may suffer from diabetes by the end 2045 all across the globe.
Similarly, the growing occurrence of atrial fibrillation is the key factor boosting the market. As per the American Heart Association Report, stroke is the prominent cause of death in the U.S., and about 2.7 million people in the country are already suffering from atrial fibrillation. It is also expected that every year, 800,000 cases of stroke has been recorded due to blockage in blood vessels.
Based on Technology, the market is segmented into Connected Wearable and Regular Wearable. Based on Application, the market is segmented into Non-Clinical and Clinical. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include DexCom, Inc., Abbott Laboratories, Koninklijke Philips N.V., Smith & Nephew PLC (Leaf Healthcare, Inc.), Qualcomm, Inc., L'Oreal Group, VivaLNK, Inc., Cardiac Insight, Inc., AliveCor, Inc. and LifeSignals Group, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Technology
- Connected Wearable
- Regular Wearable
By Application
- Non-Clinical
- Clinical
By Country
- US
- Canada
- Mexico
- Rest of North America
Companies Profiled
- DexCom, Inc.
- Abbott Laboratories
- Koninklijke Philips N.V.
- Smith & Nephew PLC (Leaf Healthcare, Inc.)
- Qualcomm, Inc.
- L'Oreal Group
- VivaLNK, Inc.
- Cardiac Insight, Inc.
- AliveCor, Inc.
- LifeSignals Group, Inc.
Unique Offerings
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. North America Wearable Patch Market by Technology
Chapter 5. North America Wearable Patch Market by Application
Chapter 6. North America Wearable Patch Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- DexCom, Inc.
- Abbott Laboratories
- Koninklijke Philips N.V.
- Smith & Nephew PLC (Leaf Healthcare, Inc.)
- Qualcomm, Inc.
- L'Oreal Group
- VivaLNK, Inc.
- Cardiac Insight, Inc.
- AliveCor, Inc.
- LifeSignals Group, Inc.
Methodology
LOADING...
